, a ubiquitous water channel membrane protein, is a major contributor to cell membrane osmotic water permeability. Arteries are the physiological system where hydrostatic dominates osmotic pressure differences. In the present study, we show that the walls of large conduit arteries constitute the first example where hydrostatic pressure drives aquaporin-1-mediated transcellular/transendothelial flow. We studied cultured aortic endothelial cell monolayers and excised whole aortas of male Sprague-Dawley rats with intact and inhibited aquaporin-1 activity and with normal and knocked down aquaporin-1 expression. We subjected these systems to transmural hydrostatic pressure differences at zero osmotic pressure differences. Impaired aquaporin-1 endothelia consistently showed reduced engineering flow metrics (transendothelial water flux and hydraulic conductivity). In vitro experiments with tracers that only cross the endothelium paracellularly showed that changes in junctional transport cannot explain these reductions. Percent reductions in whole aortic wall hydraulic conductivity with either chemical blocking or knockdown of aquaporin-1 differed at low and high transmural pressures. This observation highlights how aquaporin-1 expression likely directly influences aortic wall mechanics by changing the critical transmural pressure at which its sparse subendothelial intima compresses. Such compression increases transwall flow resistance. Our endothelial and historic erythrocyte membrane aquaporin density estimates were consistent. In conclusion, aquaporin-1 significantly contributes to hydrostatic pressure-driven water transport across aortic endothelial monolayers, both in culture and in whole rat aortas. This transport, and parallel junctional flow, can dilute solutes that entered the wall paracellularly or through endothelial monolayer disruptions. Lower atherogenic precursor solute concentrations may slow their intimal entrainment kinetics. endothelium; aorta; transcellular transport; hydraulic conductivity; tracer transport; bioengineering ABUNDANT aquaporin (AQP)1 is found in numerous mammalian tissues, including vascular endothelial cells (ECs) from human and rat coronary arteries (53), the cornea, lung capillaries, and small vessels, (25, 31, 44) , and mouse aortas (52). Swelling studies on single cells (53) and reconstructed liposomes (72) have shown that AQP1 facilitates passive osmotically driven water flows that, unlike pumps, require no ATP. AQP1 allows the passage of certain dissolved gases, e.g., nitric oxide (33), ammonia (43), and CO 2 (22, 69). Membrane electrolyte transport induces passive water transport via AQP1. AQP1 suppression in ECs decreases Na ϩ channels and Na ϩ -K ϩ -ATPase Na ϩ /K ϩ pump proteins(25). The CFTR, a Cl Ϫ transporter, and AQP1 often have similar tissue distributions. By interacting with other channels, the CFTR facilitates salt secretion in tissues, which causes passive water transport through AQP1 (31).
endothelium; aorta; transcellular transport; hydraulic conductivity; tracer transport; bioengineering ABUNDANT aquaporin (AQP)1 is found in numerous mammalian tissues, including vascular endothelial cells (ECs) from human and rat coronary arteries (53) , the cornea, lung capillaries, and small vessels, (25, 31, 44) , and mouse aortas (52) . Swelling studies on single cells (53) and reconstructed liposomes (72) have shown that AQP1 facilitates passive osmotically driven water flows that, unlike pumps, require no ATP. AQP1 allows the passage of certain dissolved gases, e.g., nitric oxide (33) , ammonia (43) , and CO 2 (22, 69) . Membrane electrolyte transport induces passive water transport via AQP1. AQP1 suppression in ECs decreases Na ϩ channels and Na ϩ -K ϩ -ATPase Na ϩ /K ϩ pump proteins (25) . The CFTR, a Cl Ϫ transporter, and AQP1 often have similar tissue distributions. By interacting with other channels, the CFTR facilitates salt secretion in tissues, which causes passive water transport through AQP1 (31) .
There are at least three well-studied systems where AQP1 plays a dominant role in water transport across a cell layer: the kidney, choroid plexus, and peritoneum. In the kidney, AQP1 is abundant in ECs of the outer medullary descending vasa recta microvasculature and in apical and basolateral membranes of the thin descending limb of Henle and proximal tubule. In the proximal tubule, salt is pumped from the lumen, which creates an osmotic gradient that concentrates the urine by extracting water via AQP1. AQP1-null mice cannot concentrate urine as well as wild-type mice (30, 65) , whereas spontaneously hypertensive rats (SHRs) have increased AQP1 and produce more concentrated urine than normotensive rats (39) .
AQP1 is located in the choroid plexus epithelium cytoplasm and apical membrane. It allows the transfer of cerebrospinal fluid to the brain and plays a role in hydrocephalus. This epithelium has 1/5 the water permeability and half the cerebrospinal fluid pressure in AQP1-null versus wild-type mice; AQP1-null mice do not suffer hydrocephalus. In contrast, SHRs overexpress AQP1 and exhibit accelerated cerebrospinal fluid exchange (45, 64) . AQP1 is present in peritoneal capillaries and postcapillary venules, the main barriers to small solute transport in peritoneal dialysis, which involves both diffusive and convective transport. Decreased/increased AQP1 yields decreased/increased water permeability, the latter without altering the osmotic gradient or small-molecule permeability (17) . In these, as in other known systems, osmotic gradients are far larger than negligible or nonexistent hydrostatic pressure gradients; thus, osmotic gradients drive AQP1 water transport.
In contrast, in the present study, we investigated the role of AQP1 in hydraulic conductivity (L p ), the ratio of transendothelial water flux (J v ) to hydrostatic pressure difference (⌬P) (63) , across cultured aortic endothelial monolayers and excised whole rat aortas with virtually no transmural osmotic differences. Here, we show that AQP1 facilitates water movement driven by large hydrostatic ⌬Ps found in conduit arteries. Such measurements are more indirect than osmotic cell swelling experiments since they involve EC layers that allow parallel paracellular water transport. To evaluate the contribution of AQP1 to J v or L p , we imposed identical ⌬Ps across whole aortic walls ex vivo or across pairs of identical confluent endothelial monolayers. We compared L p s of endothelia hav-ing normal, functioning AQP1 channels with those whose AQP1 channels were chemically blocked or knocked down via small interfering (si)RNA. Tracer experiments demonstrated that the observed J v differences were not due to changes in paracellular transport; thus, they derive from transcellular, AQP-mediated flow. Our measured L p changes led to an estimate of EC AQP1 density consistent with erythrocyte AQP1 density from osmotic swelling experiments. Transendothelial flow may have important physiological consequences. In conduit arteries, hydrostatically mediated water flow can affect metabolic access to and paracrine communication between ECs and smooth muscle cells (SMCs). As the sole source of pure water influx, it likely influences transmural solute concentration, which may affect extracellular solute binding kinetics. Rapid AQP1 upregulation by the atheroprotective transcription factor Krüppel-like factor 2 (KLF2) (32) seems to highlight the importance of AQP1 for vascular health.
MATERIALS AND METHODS

In Vitro Experiments
Cell culture, monolayer Lp, and tracer permeability. Cell culture, monolayer Lp, and tracer permeability were performed as previously described in Ref. 11 . We prepared bovine aortic EC (BAEC; VEC Technologies, Rensselaer, NY) monolayers on fibronectin-coated Transwell membranes incubated for 10 min in PBS with or without 25 M HgCl 2 and measured (15) Lp of matched monolayer pairs 4 -6 days postplating. Luminal (top) and abluminal (bottom) compartments, with the latter connected via a horizontal precision-diameter borosilicate glass tube on a spectrophotometer to a fluid reservoir (15) , all at physiological pH, sandwiched the monolayer. A 10-cmH 2O hydrostatic pressure differential across the monolayer induced transmural flow, as monitored by spectrophotometer tracking of an air bubble (15) in the glass tube. Match of a nonlinear model of flowinduced EC junction sealing (51) to bubble position versus time data yielded steady monolayer L p. Leaky monolayers with holes (Lp Ͼ 13.3 cm·s Ϫ1 ·mmHg Ϫ1 ) were not considered. The change in time (⌬t) of abluminal fluorescence intensity [calibrated to concentration (⌬C a)] tracked fluorescent solute (added lumenally at t ϭ 0) transport in eight parallel chambers, two of which measured J v as well (11) . The differential 10-cmH2O hydrostatic pressure applied across the monolayer for 2 h was followed by zero ⌬P (diffusive) for 1 h. Solute permeability was calculated as follows:
where V a is the abluminal chamber fluid volume, A is the filter surface area, and Cp is the luminal chamber fluorophore concentration, assumed time independent and large relative to the abluminal value.
Test for mercury toxicity in monolayers. HgCl 2 reversibly blocks AQP1 water pores (9, 23, 49, 66) . To test for toxicity and titrate to a nontoxic HgCl2 level, we exposed monolayers to HgCl2 concentrations (5, 10, 25, 50, 100, and 1,000 M) for 1 h, washed the samples, added propidium iodide in PBS (1 g/ml; Invitrogen) to samples, which only penetrates the membranes of dead or dying cells, and viewed samples under a Nikon Eclipse TE2000-E inverted microscope with a ϫ10 objective.
AQP1 knockdown with siRNA. Twelve-well filters (Corning 3460) pretreated with fibronectin for 1 h were plated (at 32,000 cells/cm 2 , passages 4 -7) with aortic ECs and cultured in an incubator for 3 days until confluent. We followed Michel's optimized BAEC transfection protocol (27) with either Lipofectamine 2000 (Dharmacon, Lafayette, CO) alone, Lipofectamine 2000 ϩ nontargeting (NT) siRNA, or Lipofectamine 2000 ϩ one or both targets. The optimized concentration per 1.5 ϫ 10 4 cells was 20 pM siRNA for BAECS and 10 pM siRNA for rat aortic ECs (RAECs) (5, 10, 20, 40, and 80 pM tested, 3 monolayers each). L p was measured as previously described 2 days posttransfection. Targets (antisense) were as follows: BAEC (Dharmacon), target 1 (T1) 5=-UUCUUCUUGAACUCGCUGGUU-3= and target 2 (T2) 5=-UACUCCUCCACCUGACCGCUU-3=; and RAEC, AQP1-RSS351945 (Invitrogen, Grand Island, NY), 5=-AAGAGC-UUCUUCUUGAUUUCGCUGG-3=.
Western blot analysis. BAECs or RAECs were grown to confluence, lysed with ice-cold RIPA buffer with protease inhibitor cocktails (Roche Diagnostics), and sonicated. Protein was deglycosylated and incubated in sample buffer for 10 min at 60°C to reduce multimer formation. Twenty micrograms of PNGase F-digested (New England Biolabs, Ipswich, MA) protein were loaded per well, separated on a 12% SDS-polyacrylamide gel, transferred to polyvinylidene difluoride membranes, blocked, immunoblotted, immunoreactivity visualized (enhanced chemoluminescence kit, Amersham, Arlington Heights, IL), and densitometry probed with ImageJ (National Institutes of Health). Membranes were reprobed with ␤-actin (42 kDa) antibody as a loading control. We report percent knockdown relative to control. AQP1 blocking peptides (AQP1-P, Alpha Diagnostics, San Antonio, TX), which disrupt antigen-antibody binding, served as an AQP1 antibody blocking control.
RT-PCR. We extracted RAEC RNA in the presence of RNase inhibitor, synthesized cDNA, performed PCR, separated PCR products, and detected with ultraviolet light. Quantitative RT-PCR amplification was done on 25-l mixtures of 2ϫ SYBR green fluorescein mix (Thermo Fisher), 70 nM primers, and 250 ng cDNA templates. An initial 5-min 95°C denaturation preceded fifty 30-s cycles at 94, 55, and 78°C. A negative nontemplate control was used. A dissociation curve analysis assessed product amplification specificity after each PCR. Target gene/ primer sequence pairs were as follows: AQP1 (18) 
Ex Vivo L p(⌬P) Measurements
All animal protocols were approved by the Institutional Animal Care and Use Committee.
The aortas of male Sprague-Dawley (SD) rats (350 -400 g) on a normal diet were removed under transmural ⌬P, flushed with a perfusate solution [4% (wt/vol) BSA in PBS with 10 Ϫ3 M NaNO3 and 0.03% trypan blue (vital stain and leak reporter)], and submerged in a petri dish with the same solution minus trypan blue (which has a negligible effect on its osmotic pressure) as previously described in Ref. 55 . The proximal end of the aorta was connected to reservoir 2 ( Fig. 1 ; valves not shown) via a spectrophotometer bubble tracking system adapted from Ref. 15 that was identical to the in vitro Lp system described above. A distal cannulata connected it to a perfusate solution and pressure reservoirs whose pressure was adjusted by a mercury sphygmomanometer pump. Preconditioning (lowering and raising vessel ⌬P to its minimal and maximal physiological ⌬P three times, each for Ͻ1 min) reduced hysteresis.
Transmural flux measurements. After pumping reservoir D to the desired ⌬P, we opened the proximal valve. The bubble tracking device measured the flow rate of fluid entering the vessel and exiting its walls. We only used data steady for Ͼ30 min. A mechanical caliper accurate to Ϯ0.1 mm (55) measured vessel geometry before and 6 and 30 min after pressurization to track myogenic changes. We repeated this procedure for each ⌬P. Next, to block AQP channels, a ϳ5-mmHg ⌬P drove the HgCl2 solution from reservoir C through the vessel for 10 min. We flushed for 10 min and remeasured Lp(⌬P). To deendothelialize the vessel, we opened the proximal tie, inserted a 3-or 4-mm Foley catheter with a small Epon ball on its tip, advanced it to the distal end, and removed it with a slow rotation. After a 5-min flush at 10 mmHg from reservoir A, we retied the proximal cannula and remeasured L p(⌬P Electron microscopy. Two male SD rats (8 rats total) were used for 50 and 100 mmHg with and without HgCl2 treatment. A carotid artery cannulation connected the anesthetized, ventilated rat to a constant pressure reservoir. After the heart was stopped, a heparin-PBS rinse from the carotid artery to the femoral artery ran until the effluent was clear. Next came a 5 M HgCl 2-PBS or pure PBS flush at ⌬P for 10 -15 min and glutaraldehyde-PBS at the same ⌬P for 2 h (in situ fixation). The aorta was removed, placed in glutaraldehyde for 24 -48 h with osmium tetroxide, embedded in resin, sectioned to 900Å (gold reflection) with a diamond knife in an LKB Ultramicrotome 4801A, stained with uranyl acetate and lead citrate, and viewed with a transmission electron microscope (Zeiss Electron Microscope 902).
Immunochemistry
Monolayers. The monolayer protocol used was similar to that previously described in Ref. 68 . Briefly, confluent BAEC monolayers grown on Transwell filters were fixed with PLP fixative, permeabilized with 0.075% saponin-PBS, and blocked with 15% goat serum, 0.3% Triton X-100, 20 mM sodium phosphate, and 0.9 mM NaCl. After exposure to rabbit anti-rat AQP1 primary antibody (Alpha Diagnostics; 1:250 dilution) in 15% goat serum, 0.2% BSA, and PBS and then to secondary antibody (Alexa 488-conjugated goat antirabbit IgG, Molecular Probes, Carlsbad, CA; 1:200) in 1% goat serum and PBS, samples were counterstained with 4=,6-diamidino-2-phenylindole (DAPI; 1:3,000), cut, mounted with Vectashield, and viewed under a Zeiss 510 confocal microscope with same laser intensity/exposure time for all samples.
Vessel sections. Ventilated 250-300 g male SD rats were euthanized and perfused with 0.3 ml heparin (5,000 USP units/ml, China Chemical & Pharmaceutical, Taipei, China) in 60 ml PBS from the carotid cannula to the femoral artery until the effluent was clear followed by Accusan Bouin's fixative (Sigma Chemical, St. Louis, MO). The aorta was removed, further fixed in Bouin's fixative, and stripped of adventitia and connective tissue. The aorta was then cut into segments, washed in 70% alcohol plus several drops of NaOH, placed in 30% sucrose overnight at 4°C, and embedded in Tissue Tech OCT compound (Tissue-Tek, Sakura Finetek, Torrance, CA). Afterward, the aorta was cryostat (Microtome Cryostat Cryostar HM 560 MV) sectioned to 10 m onto Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) and stained with hematoxylin (48) with or without Slow Fade Gold antifade with DAPI (Invitrogen, Carlsbad, CA). Pontamine Sky Blue 6BX (0.5%; Alpha Aesar, Haverhill, MA) restricted elastic's broad-spectrum autofluorescence to red (13) . Immunochemistry was done as in culture except that 0.05% saponin was added to the blocker, the primary antiserum was in 3% goat serum, 0.2% BSA, and PBS (1:500) for 18-24 h, and secondary antibody was diluted to 1:50. Samples were mounted with Vectashield media (clear nail polish secured the coverslips) and viewed under a Leica TCS SP2 AOBS confocal microscope with Leica TCS SP/NT 2.5 version 2.51347d image-analysis software or a Zeiss LSM510 confocal microscope with LSM 3.5 SP 1.1 software.
Calculations
L p was determined using the following equation:
where v is the bubble front meniscus velocity, A is the tubing cross-sectional area, OD is the average outer diameter, and L is the length. ϫ OD ϫ L is the vessel outer surface area.
Osmotic gradients across large vessel walls are generally assumed negligible. Thus, L p of the intact entire vessel wall (Lp t ; Fig. 2A ) can be related to that of the denuded vessel [media ϩ internal elastic lamina (IEL); L p m ϩ I ] and endothelium ϩ subendothelial intima (SI) (Lp e ϩ i ) by the sum of specific resistances (1/Lp) (63) as follows:
Vessel Lp experiments measured three sets of Lps on each vessel (intact, after HgCl2 AQP1 blocker, and denuded), each at the same three ⌬Ps. 
Statistics
Values are presented as means Ϯ SE. We calculate P values from unpaired (paired 1 ) Student's t-tests for two columns of unpaired (paired) data and from ANOVA (with subsequent Tukey tests when appropriate) for multiple data columns. P values of Ͻ0.05 were considered significant. For more complex comparisons of two types of experiments that measured similar information, we used bootstrap (14, 21) nonparametric methods, which are detailed in the APPENDIX. Figure 3A shows a confocal section of immunocytochemically and DAPI-treated BAECs grown to confluence on a Transwell filter with xz and yz views; Fig. 3B shows the three-dimensional reconstruction. The isotype control (not shown) was nearly black. Blue (DAPI) stain indicates cell nuclei. Green (Alexa 488) stain indicates that BAECs avidly express AQP1 in some cultured cells, including around the nuclei and far from the perinuclear region. Fig. 3C shows a 200-nm confocal optical slice from a 10-m transverse section of an SHR thoracic aorta. The result for a normotensive SD rat (not shown) was similar. Here, green again indicates AQP1, since we restricted tissue autofluorescence to red, as described above. The top red band is the IEL. DAPI (blue) labeled EC (SMC) nuclei above (below) the IEL, establishing AQP1 expression in both cell types in conduit arteries, as previously described for SMCs (53) . To verify that all tissue autofluorescence was pushed into red, we performed the procedure without either antibody. To test for nonspecific primary antibody binding, we did a small peptide control to the primary antibody's AQP1-binding site (Fig. 3D ). To test for nonspecific secondary antibody binding, we used secondary antibody but no primary antibody. All three controls showed red bands but no visible green fluorescence.
RESULTS
For a transcellular AQP water transport pathway, it is necessary (but not sufficient) that AQP1 be present both on the luminal and abluminal parts of the cell membrane. Fig. 3E shows the superposition of 50 serial, high-magnification 200-nm optical confocal slices through an EC from a 10-m transverse section of an SHR [normotensive SD (not shown) similar] thoracic aorta. Our custom software creates a blue outline (tracing the maximum gradient in green intensity) to surround the region of intense, albeit uneven, green stain above the IEL. Superimposed on the confocal image is the black-andwhite transmission image, blurry at high magnification. The near coincidence between the transmission image cell border and the blue outline of the green region indicates that AQP1 fluorescence extends to and includes both EC luminal and abluminal membranes. This bilateral distribution makes plausible transcellular trans-AQP1 water transport.
This plausibility motivated functional water transport experiments. We subjected matched (i.e., treated exactly the same) pairs of BAEC monolayers cultured on fibronectin-coated Transwell filters (15) , one with and one without 25 M HgCl 2 , an AQP blocker (49) , to a 10-cmH 2 O hydrostatic ⌬P and measured J v across the monolayer versus time (15) . This ⌬P induces a J v similar to that in large arteries in vivo. Hg 2ϩ blocks AQP1 water transport by binding to Cys 189 at AQP1's pore entrance (49) but can be cytotoxic above certain concentrations/exposure times. Propidium iodide staining, which only penetrates the membranes of dead/dying cells (i.e., toxicity), was only present at HgCl 2 concentrations above 50 M; 25 M yielded no evidence of toxicity. Human intestinal Caco-2 cells exposed to 100 M Hg 2ϩ showed no diminution in cell viability (1) . Twenty-five micromolars is 1/40 the concentration used to block AQP1s in vascular SMCs (53) but is enough to block ϳ90% of AQP1 in murine erythrocytes (70) . In each matched pair of monolayers, L p was significantly lower (22 Ϯ 6%, n ϭ 4 monolayer pairs, percent drops: 16.0%, 18.4%, 24.1%, and 29.9%, P ϭ 0.0057; Table 1 ) in monolayers exposed to HgCl 2 ; toxicity would have caused it to rise.
To test if HgCl 2 treatment affected monolayer integrity, as reflected in paracellular transport, we performed 70-kDa dextran [ϳ7-nm radius (19) ] solvent drag experiments. HgCl 2 altered neither its diffusive permeability (P 0 ) nor convective permeability (P c ) significantly (Table 1 ; note the large SE for P c ); thus, HgCl 2 did not harm monolayer barrier function. Since 70-kDa dextran only crosses the monolayer paracellularly, its nonsignificant P 0 change indicates that the observed L p drop is not likely due to junctional (paracellular) changes. We also performed solvent drag experiments with TAMRA, a smaller tracer (0.8-nm radius) that also only crosses the monolayer paracellularly 2 . As shown in Table 1 , TAMRA P 0 ϭ P c , neither of which changed significantly with HgCl 2 . P 0 ϭ P c means that the diffusive far exceeds the advective contribution to its transport, which implies (APPENDIX) that the ratio of control-to-treated P 0 s equals the ratio of control-to-treated junction pore widths. If all transport were paracellular (and Darcy; the APPENDIX gives the Poiseuille alternative), this ratio of pore widths would also equal the ratio of control-to-treated L p s (Fig. 2B ). Since HgCl 2 caused a significant 22% drop in L p with a statistically insignificant, yet ϳ17%, change in P 0 , we used statistical tests to see how unlikely the L p drop is due to paracellular, i.e., pore width changes. A t-test showed that the sets of ratios 3 of P 0 s and L p s were indeed different (P ϭ 0.004; Table 1 ), i.e., arose from different distributions. A further check is that of nonparametric bootstrap (14, 21) statistic S (APPENDIX), which is zero if all water transport is paracellular and negative if there is nonparacellular water transport that decreases upon HgCl 2 exposure. With 99% probability, S had mean Ͻ Ϫ0.05 (see Fig. 7B ). Both tests indicated that HgCl 2 -induced pore width (or P 0 ) changes are very unlikely to explain the drop in L p with HgCl 2 : thus, water transport is very unlikely purely paracellular. The siRNA results described below make an even stronger argument for the same conclusion.
Since HgCl 2 blocking is nonspecific, we validated these results with siRNAs against bovine AQP1 mRNA on BAEC monolayers (27) . Western blots (Fig. 4A ) and densitometry demonstrated that T2 induced 70.3% (n ϭ 4, P Ͻ 0.001) AQP1 (28 kDa ϩ 56 kDa) knockdown relative to the 42-kDa ␤-actin control. L p s for BAEC monolayers judged nonleaky showed a 53% (P ϭ 0.04) drop in L p (7. , n ϭ 6) from scrambled NT siRNA in pooled data from T2 alone and 20 pM each of T1 ϩ T2-treated monolayers; T1 had no effect on L p . We repeated these experiments on RAECs to compare with rat aorta experiments.
Analogous siRNA knockdown experiments for RAEC monolayers gave similar results. Western blots showed a 67.9% drop in the 56-kDa AQP1 dimer band (n ϭ 2, P ϭ 0.001; Fig. 4B ) and a smaller change in the 28-kDa monomer band for a 59.2% drop (n ϭ 2, P ϭ 0.00084) in the 28-kDa ϩ 56-kDa bands relative to the ␤-actin control. Higher multimer bands showed no significant change. Quantitative RT-PCR, given as 2 Ϫ⌬⌬C T (where C T is threshold cycle), normalized to endogenous control (GAPDH) relative to untreated control, showed a 0.47 (ϩ0.28/Ϫ0.18) 4 -fold change of AQP1 relative to control, i.e., a ϳ53% siRNA-induced drop in AQP1 mRNA (n ϭ 3). Treated and control groups showed no drop [2 Ϫ⌬⌬C T ϭ 0.98 (ϩ0.11/Ϫ0.10)] for von Willebrand factor (n ϭ 3). Corresponding to AQP1 knockdown, we found a 56.4% (n ϭ 7) reduction in mean monolayer L p for this target siRNA (Table 2) . L p for no treatment, Lipofectamine 2000 alone, and Lipofectamine 2000 ϩ NT siRNA (not shown) were nearly identical. Table 2 shows albumin (radius: 3.5 nm) and TAMRA solute drag results on control versus knocked down RAEC monolayers. The larger molecule, here albumin, had P 0 P c
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. As with HgCl 2 / BAECs, P 0 (barrier function) was unaffected by siRNA (twotailed t-test). The smaller molecule, TAMRA, had P c Ϸ P 0 for both treated and control monolayers, i.e., diffusive dominated advective TAMRA transport, with neither P c nor P 0 affected by siRNA. Insignificant (Ϫ0.7%, 16.7%) solute tracer P 0 differences were far too small to explain the 56.4% siRNA-induced L p drop. This indicates transcellular water flow. A t-test showed that post-to-pretreatment ratios of L p s and TAMRA P 0 s were different (P ϭ 4.0 ϫ 10
Ϫ8
; Table 2): they came from different distributions. The mean of the bootstrap statistic was less than Ϫ0.52 Ӷ 0 with 99% confidence (see Fig. 7A ). Thus, with extremely high confidence, L p has both paracellular and nonparacellular contributions and siRNA AQP1 knockdown reduced the latter significantly in RAEC monolayers.
To assess AQP1's contribution to whole vessel L p , we measured L p on each aorta at three ⌬Ps (as in Refs. 4 and 63) multiple times after various treatments. We first carried out controls to validate our technique and to assess toxicity. The results shown in Table 3 demonstrate that a flush driving ⌬P of 5 mmHg left L p unchanged. The results shown in Table 4 demonstrate that a 10-min flush of 5 M HgCl 2 [which gives ϳ40% osmotic permeability inhibition in erythrocytes (70)] followed by a 10-min wash to remove unbound Hg 2ϩ lowered L p at all ⌬Ps. 2-Mercaptoethanol returned L p to baseline at all three ⌬Ps. [Note that the drop in L p with HgCl 2 was larger at 60 mmHg (24%) and 45 mmHg (31% and 38%) than at 100 mmHg (7%, 18%, and 17%)]. Electron micrographs of control and HgCl 2 -treated rat aortas fixed at 50 and 100 mmHg showed no EC morphological changes (Fig. 5) . These L p experiments and micrographs indicate that the 10-min 5 M HgCl 2 exposure was not EC toxic.
The results shown in Fig. 3C confirm the well-known (53) fact that vascular SMCs express AQP1. To exclude the possibility that blockade of SMC AQPs caused the observed vessel wall L p t changes, we denuded the aortic endothelium, measured baseline L p (⌬P), flushed with HgCl 2 , and remeasured L p (⌬P). The results shown in Table 5 demonstrate that there were no significant L p changes due to flushing a partially, fully (later with no modifier), or vigorously denuded (vigorous working of the catheter back and forth may affect the IEL) vessel with HgCl 2 . Thus, blockade of SMC AQPs did not measurably decrease vessel wall L p t . L p s of denuded SD rat aortas (Fig. 6A ) treated with HgCl 2 before denudation were similar to L p s of denuded aortas both before and after HgCl 2 treatment (Table 5) and to L p s of denuded Wistar-Kyoto rat aortas (n ϭ 5, not shown) of the same age/weight not exposed to HgCl 2 . Figure 6A shows L p t at ⌬P ϭ 60, 100, and 140 mmHg at baseline and after HgCl 2 and L p m ϩ I after denudation, with all nine measurements taken on each vessel (n ϭ 6). Each intact vessel L p t dropped at every ⌬P with HgCl 2 . Figure 6B shows a plot of mean Ϯ SE values of the percent L p t drop of a vessel with HgCl 2 versus ⌬P, which brings this out. At 60 mmHg, HgCl 2 decreases intact vessel L p t by 32 Ϯ 4% and less at ⌬P Ն 100 mmHg, as also seen in the controls in Table 4 . Equation 1 (63) relates the apparent resistance, 1/L p e ϩ i , of the endothelium ϩ SI to L p t and L p m ϩ I (Fig. 6A) . HgCl 2 increased the average
, of the total wall resistance from 26 Ϯ 8% to 56 Ϯ 5% at 60 mmHg. Since HgCl 2 does not affect medial resistance, it increased this fraction by decreasing L p e ϩ i 51 Ϯ 2.3% (average percent difference, not the percentage of average difference, since all measurements were done on each vessel) from 6.28 to 3.13 ϫ 10 Ϫ8 cm·s Ϫ1 ·mmHg Ϫ1 [n ϭ 5; with one outlier (n ϭ 6), the drop was 58 Ϯ 2%] at 60 mmHg (Fig. 6C ). If these percent changes simply represented a decrease in native endothelial L p e , they would be ⌬P independent. The data evinced smaller, yet significant (P Ͻ 0.05), percent drops in L p e ϩ i and L p t at the higher ⌬Ps: 21 Ϯ 4% and 11 Ϯ 2% at 100 mmHg and 11 Ϯ 7% and 5 Ϯ 3% at 140 mmHg. ANOVA on the curves shown in Fig. 6 , A and C, demonstrated that the flushed (A and C) and denuded (A) curves were flat, i.e., ⌬P independent (P Ͼ 0.05), but that baseline L p e ϩ i (neglecting one outlier) and L p t at 60 mmHg differed (P Ͻ 0.05 by ANOVA) from their (indistinguishable) values at 100 and 140 mmHg. L p t (n ϭ 2, not shown) with HgCl 2 showed that lowering ⌬P from 60 to 20 mmHg raised L p t by 17.4 Ϯ 8.6%.
DISCUSSION
Immunochemistry demonstrated that cultured aortic ECs and RAECs in whole aortas express AQP1 (Fig. 3) . Expression levels varied far more in culture than in vessels, likely due to the nonphysiological ⌬P ϭ 0 and high protein culture medium The control was a flush with HgCl2; Cys-Hg 2ϩ was then reduced with 2-mercaptoethanol.
for growth to confluence. Quiescent cells likely also express differently from recently proliferative cells. The near coincidence of the transmission image's EC border and outline of the green (AQP1) region in the superposition of serial confocal sections (Fig. 3E ) establishes AQP1 expression throughout whole aorta ECs, including luminal and abluminal membranes; thus, AQP1-mediated transcellular water flow is plausible.
In Vitro Experiments
L p experiments on AQP1 knocked down BAEC and RAEC monolayers (Table 2) , confirmed by Western blots and RT-PCR, and on BAEC monolayers with HgCl 2 -blocked AQPs (Table 1) showed that reducing functioning EC AQP1 significantly reduced monolayer L p . 6 The reduction was larger for siRNA than for HgCl 2 , likely because HgCl 2 concentrations used to avoid toxicity probably reduced AQP function less than siRNA.
HgCl 2 did not significantly affect monolayer 70-kDa dextran P 0 ; this verified monolayer integrity. Since 70-kDa dextran only crosses the endothelium paracellularly, the unchanged P 0 indicates unchanged junctional transport: the L p drop was not due to junction strand changes or to junctional changes from cell swelling (5, 6), possibly secondary to Hg 2ϩ blockade of AQPs (65) . TAMRA is a tracer large enough to only pass through the large junction pores for water (28) , yet small enough that, even with a 10-cmH 2 O ⌬P-driven flow across the monolayer, the diffusive far exceeds the advective contribution to its transport (P 0 Ϸ P c ). Challenging matched pairs of control versus HgCl 2 -blocked BAEC monolayers with TAMRA showed that changes in P 0 do not explain the observed L p drops with HgCl 2 . Similar tracer and L p experiments on AQP1-knocked down RAEC monolayers confirmed this more strongly; they clearly indicated (ϾϾ99% confidence) that AQP1-mediated transcellular water transport represents a significant fraction of L p e . 6 Concentration polarization, the buildup of solute on the upstream side of a filter, can affect the value of Lp inferred from flow data. As long as the perfusate albumin concentration is Ͼ1 g/dl (we used 4 g/dl), the surface glycocalyx is saturated and the concentration polarization effect is weak (60) . Since our filtration rates are at most within a factor of two (usually far less) of each other, any concentration polarization might affect absolute Lp, but not significantly the relative post-to-pretreatment Lp t values, especially not whether they go up or go down, which is our concern. Gao et al. (25) added anti-AQP1 siRNA, transfection reagents, and 10-kDa dextran (radius: ϳ3 nm, between TAMRA and 70-kDa dextran) together to cultured human pulmonary vasculature EC monolayers. They found that total tracer diffused across the layer doubled over the ensuing 24 h in the presence of reagents that affect EC membranes and junctions while knockdown and other dynamic changes occurred. Our study, on different cells, found a decrease in the instantaneous, i.e., 1 h, permeability of an already-knocked down, nonzero ⌬P-adjusted monolayer in physiological media. It is impossible to compare these vastly different experiments.
Whole Vessel Experiments
We use rat, rather than the much smaller AQP1 knockout mouse, aortas because adequate L p technique signal/noise requires a minimum endothelial area and transendothelial flow. The thin lubricating layer surrounding a tracked bubble that moves too slowly can break; the bubble then sticks to the tube wall (26, 46) , which compromises the measurement.
The HgCl 2 concentration [which only negligibly inhibits ion transporters (37)] in our intact aorta study is lower than in our BAEC experiments, yet more effectively inhibits endothelial L p . This is likely because, as noted, fewer ECs in culture express AQP1 as strongly as in vessels. Different conditions can yield different EC AQP1 functions and localization, e.g., AQP1 in rat choroid plexus epithelial cells mainly localizes in the apical cell membrane but shifts to the cytoplasm in cells of rats with increased choroid plexus pressure (hydrocephalus). A PKC mechanism (45) causes ⌬P-induced AQP1 shuttling. Fluid shear at 1 dyn/cm 2 causes AQP2 translocation to the renal epithelial cell membrane (38) , where it participates in transcellular flow (10) . Doubling the perfusion rates in isolated renal microtubules for 15 min doubles AQP1 in the brushborder apical and basolateral membranes (47) . Quiescent ECs exposed to large ⌬P and shear, as in whole vessels but not in our monolayers, have tighter cadherin junctions and greater plasma membrane AQP1 content (42), i.e., lower junctional and higher transcellular flow: AQPs account for a larger share of transendothelial flow; thus, AQP blockade decreases L p more in vessels than in culture.
HgCl 2 blockade of EC AQP1 reduces whole rat aortic wall L p t ex vivo by 32 Ϯ 4% at 60 mmHg. HgCl 2 exposures cause no significant cytotoxicity; no morphological changes appear, and removal of Hg 2ϩ with 2ME returns L p t to control values. HgCl 2 does not change denuded vessel L p m ϩ I (Table 5) . Thus, L p m ϩ I represents the far less resistant route through the extracellular matrix around the SMCs (which lack tight junctions) rather than the parallel trans-SMC AQP1 path. Thus, the 32 Ϯ 4% HgCl 2 -induced L p t reduction can only result from a reduction of its endothelium ϩ SI conductivity (L p e ϩ i ) by 51 Ϯ 7% (Eq. 1). An estimate that half of the ⌬P-driven transendothelial J v is transcellular would be surprisingly high.
If this L p e ϩ i reduction were all in native endothelial L p e , it would be ⌬P independent. Yet, L p t and L p e ϩ i drop far less at 100 and 140 mmHg. This suggests that structural changes, as previously demonstrated without HgCl 2 (4, 55, 63) , may contribute. L p t versus ⌬P has a step shape: high at 60 mmHg, sharply reduced by 80 -100 mmHg, and flat to Ͼ140 mmHg. L p m ϩ I (denuded endothelium) is ⌬P independent at approximately twice intact vessel L p t at high ⌬P. Normal intact rat aorta SI (ϳ200 nm), composed of collagen and a loose extracellular matrix, is mostly void [ϳ93% sucrose space (35) ]. A fenestrated IEL separates it from the Ͼ100-m-thick and far denser media [ϳ42% sucrose space (62)]. We have proposed (35) that rising ⌬P pushes ECs against the IEL and dense media. This decreases SI fiber spacing and causes ECs to obstruct IEL fenestrae ( Fig. 2A) , which substantially raises flow resistance/lowers L p t . Firm, load-supporting SI collagen (Table 5) , changes in Lp t reflect changes in endothelium ϩ SI Lp e ϩ i (points); numbers above the points are means Ϯ SE of percent drops in Lp e ϩ i with HgCl2. These differences are distinguishable (P Ͻ 0.005) for 60 mmHg versus the other pressures only.
(This figure and these statistics neglect the lone outlier that showed nearly no difference between Lp t and Lp m ϩ I , and thus a huge Lp e ϩ i , at 60mmHg only; the mean Ϯ SE for the percent drop including this outlier at 60 mmHg was 56 Ϯ 7.4%). Lp e ϩ i dropped by more than half at 60 mmHg. n ϭ 6.
fibers limit compression/L p drop. Denudation removes endothelial resistance and EC fenestra clogging; a higher, ⌬P-independent L p m ϩ I results. Theory has predicted (35) a six-to sevenfold versus subsequently observed (34) fivefold SI compression. The study of Huang et al. (34) shows direct EC fenestral blockade. Even though the percent drop in L p t with HgCl 2 blockade is ⌬P dependent (Fig. 6) , the blocked L p t values are approximately ⌬P independent, particularly for 60 -100 mmHg. This suggests that AQP1 blockade lowers the critical ⌬P to compact the SI/block fenestral: it shifts the step in L p t versus ⌬P leftward to lower ⌬P. Analogously, a weaker wind (⌬P) drives a sailboat with an intact sail (blocked AQPs) as fast as a stronger wind drives a boat with a sail with holes (functioning AQP1s). AQP1 blockade not only reduces intrinsic endothelial L p e , but it also shifts part of the total ⌬P ϭ force/area from the media to the endothelium. This lowers the total ⌬P needed to achieve the critical force/area on the endothelium for SI compression. At 60 mmHg, HgCl 2 exposure lowers L p e and causes an uncompressed SI to compress; both effects lower L p e ϩ i . Thus, AQP1 represents Ͻ52% of L p e , yet HgCl 2 still causes the large observed drop in L p e ϩ i and L p t . At 100 and 140 mmHg, the SI is compressed without HgCl 2 ; thus, the drops in L p e ϩ i and L p t with HgCl 2 are smaller.
The APPENDIX estimates SI pressure and critical transendothelial pressure for SI compression. Table 6 shows the results. The results predict that HgCl 2 lowers ⌬P for SI decompression from 60 to Ͻ46 mmHg and, with HgCl 2 , that L p t is ϳ22% higher below 46 mmHg than at 60 mmHg. Measurements (n ϭ 2) found that L p t with HgCl 2 was 17.4 Ϯ 8.6% higher at 20 mmHg than at 60 mmHg.
From estimates of the portion of L p e due to AQP1 in whole rat aortas and of l p of a single AQP1 from an osmotic swelling study [ϳ1.3-2.6 ϫ 10 Ϫ19 cm 3 ·s Ϫ1 ·mmHg Ϫ1 ·AQP Ϫ1 (72)], one can estimate the EC membrane AQP1 density and compare it with literature values for red blood cell (RBC) membranes. The APPENDIX constructs a series/parallel AQP1 and junctional flow scheme (Fig. 1B) that, with the data shown in Fig. 6 , found ϳ1.1-2.2 ϫ 10 11 AQPs/cm 2 membrane in ECs (ϳ29 -44% of 
Summary and Significance
Osmotic differences (osmotic gradients) drive water across the well-studied family of AQPs. Large arteries are the physiological system where hydrostatic ⌬P dominates osmotic gradients. Here, we show, for the first time, that ⌬P drives water across arterial ECs via AQP1. AQP1s account for part of L p e and L p t , particularly under wall shear, as in vessels, which likely shifts AQP1 to the cell membrane (47) . They set the critical transmural ⌬P for the SI compression and the net force/area that ECs feel at a ⌬P (Table 6 ). These all have potentially important effects on EC regulation, membrane and cytoskeletal structure, junctional integrity, and conduit artery mural and barrier function. By controlling L p t , AQP1s may contribute to vessel wall health and pathology by regulating nutrient, catabolite, signal, and harmful solute advection and thus may be attractive drug targets.
The role of AQP1 in arterial endothelial L p e and wall L p t may be relevant to early atherogenesis. Low-density lipoprotein (LDL)-cholesterol (diameter: ϳ23nm) transport from the blood into the arterial SI and its subsequent binding to the SI extracellular matrix are key early atherogenic events (56) believed to trigger lesion formation (59) . LDLs do not appear to cross the endothelium uniformly but rather focally by ⌬P-driven advection (61) around rare [ϳ1/(2,000 -6,000) ECs in the rat aorta (40) ], isolated ECs with temporarily loose junctions (36, 58, 67, 73) . L p t -controlled transmural flow can dilute SI LDL, thereby likely slowing its extracellular matrix binding kinetics (24, 71) , and flush the SI of unbound LDL. Lower L p t may impair dilution and clearance. This may be one reason that (pulmonary) hypertension is a strong risk factor for (pulmonary) atherosclerosis (20): chronic hypertension causes SI, subendothelial intima; ⌬P, pressure difference; Lp t , Lp of the intact entire vessel wall; Lp m ϩ I , Lp of the denuded vessel (media ϩ internal elastic lamina); Lp e , Lp of the endothelium; Lp e ϩ i , Lp of the endothelium ϩ SI; Lp i ϩ f , Lp of the SI ϩ fenestrae; PL, lumen pressure; Pi, SI pressure. *Lp m ϩ I is ⌬P and HgCl2 independent (Fig. 6A , Table 5 ). We use Lp m ϩ I at 60 mmHg, and no HgCl2 for the entire estimate for consistency. The average experimental value at each condition differs insignificantly from it. Because of this difference, the resulting estimated value (2.05) for LPt differs (**) from the experimental value (1.84) at 100 mmHg, no HgCl2. This LPt estimate plays no part in the estimation calculation; it is included for completeness.
artery walls to remodel to a thicker and denser media and the SI to become cellular (29) , which significantly lower L p t versus normotension. Not only might medial thickening regulate L p t over many months (29) , but differential AQP1 expression might allow active, rapid L p t regulation. At a mean physiological ⌬P ϳ 100 mmHg, the SI is fully compressed but close to decompression ⌬Ps (3, 55) . Figure 6 shows that SI compression decreases L p t by ϳ1/3; thus, SI decompression at normal or hypertensive ⌬P can potentially raise L p t by ϳ50%. Coronary arteries experience ϳ20% lower systole ⌬P than the aorta when their blood flow is generally blocked (7) . These vessels may be particularly susceptible to SI decompression, via naturally or pharmacologically increased EC AQP1 channels, to slow lipid transport and SI extracellular matrix binding. The next step is to observe disease progression in lipid-fed apolipoprotein E-deficient mice with normal and reduced AQP1. Unfortunately, the AQP1 knockout mouse suffers microcardia, reduced stroke volume, thin vessel walls, and hypotension (41) . A model with reduced AQP1 only in conduit arteries but not elsewhere would be ideal.
EC-derived KLF2 facilitates atheroprotective EC and SMC phenotypes and induces exosomal transport of microRNAs from ECs to SMCs to produce a nonproliferative SMC phenotype (32) . One of its earliest effects is AQP1 upregulation (8) . Shear upregulates KLF2. KLF2 is expressed nonuniformly in arteries, with far lower expression at arterial branch points (2), the sites of low shear and high EC turnover, tracer permeability, and atherosclerosis proclivity (12) . This is consistent with more solute, fewer AQP1 and less water transport. Since EC-derived nitric oxide exits ECs via AQP1 (7), ECs with fewer functioning AQP1s (at branches or via blockade or knockdown) likely transport less nitric oxide to medial SMCs. In contrast, in straight arterial regions, wall shear stress yields lower EC turnover and an endothelium less permeable to large solutes (25) and with lower inflammation (8) . KLF2/AQP1 induction may reduce inflammation by slowing SI lipid entrainment that attracts monocytes that mature to macrophages.
APPENDIX: TECHNICAL ARGUMENTS
The Meaning of Lp Ratios and TAMRA Tracer Permeability P0 Ratios
The results show that HgCl 2 (siRNA) treatment of BAECs (RAECs) reduces Lp significantly and does not change P0. Rather than concluding from this qualitative argument that Lp represents paracellular and transcellular flow, we invoked two statistical tests with the following background. Diffusive transport under a fixed concentration gradient is proportional to the open junction cross-sectional area, which is, to a very good approximation, the total junction length (L) in the monolayer times the mean junction width (h). If L is the same for all monolayers of a given cell type (BAEC or RAEC), a lower diffusive transport indicates a smaller h. Liquid flow through a porous media obeys Darcy's law, and the Darcy flow rate through a slit (the junction) is proportional to h; thus, the Darcy flow across the monolayer is also proportional to h. If all transendothelial flow were paracellular, then both the post-to-pretreatment ratio of Lp and of P0 would each reflect the post-to-pretreatment ratio of h (Fig. 2B) (assuming a Poiseuille junction flow means that the junctional portion of Lp goes ϳh 3 rather than ϳh); measuring Lp and P0 ratios would then sample the same distribution of post-to-pretreatment h ratios. Tables 1 and 2 show P values (4 ϫ 10 Ϫ3 for BAECs and 4 ϫ 10 Ϫ8:
for RAECs) comparing the sets of Lp and P0 ratios; the results showed that they were different, i.e., they arose from different distributions. This means that L p is not just paracellular flow.
Bootstrap Statistics
The bootstrap (14, 21 ) is a resampling method that allows testing of a statistical hypothesis based on the resampling of acquired data to get the distribution of a derived statistic. The key point of these methods is that after each sampling of this statistic, one returns the randomly selected datum to the pool from which the next sample is chosen. The distribution of the derived statistic results, from which one can determine confidence intervals for that statistic.
To construct a test statistic, let superscript 1 on L p and P denote mean posttreatment and superscript 0 denote mean pretreatment (with the "0" in P 0 dropped for clarity). Define statistic S as the ratio of Lps minus the ratio of TAMRA P0s (or, for Poiseuille flow, of its cube). S has a mean zero for purely paracellular water transport. The following equation results:
If part of the water transport is transcellular and treatment increases that portion, with the paracellular portion unchanged, then S is positive 7 . Let the null hypothesis be S Ն 0: either transport is purely paracellular or treatment (BAECs: HgCl 2 exposure; RAECs: anti-AQP1 siRNA) increases or does not decrease transcellular transport fast enough. Figure 7 shows the distributions of S for RAEC (A) and BAEC (B) data for Darcy flow (j ϭ 1). In both cases, nearly all of the distribution's mass is left of zero, with 99% confidence for BAECs that S is negative (less than Ϫ0.050) and 99% confidence that S for RAECs is (very) negative (less than Ϫ0.52). The confidence for RAECs is better because n is larger for the L p experiments on RAECs than on BAECs and the variances of both Lp and solute drag experiments for siRNA on RAECs are tighter than for HgCl2 on BAECs. Poiseuille junction flow (j ϭ 3) gives (not shown) a similar confidence interval for RAEC data and Ͼ96% confidence that the test statistic is negative (less than Ϫ0.0035) for BAEC data. Thus, we reject the null hypothesis and conclude that L p has both transcellular and paracellular contributions and that treatment decreases transcellular transport. Tables 1 and 2 show these statistical results for BAEC and RAEC data.
Details of the Estimate of the Pressure Needed to Decompress the SI in the Presence of HgCl 2 and of the Corresponding Lp t
Let PL, Pi, and Pa be lumen, SI, and adventitial pressures, respectively, with ⌬P ϭ PL Ϫ Pa. At steady state, Jv across the whole wall equals both that across the endothelium and that across the media. Each flux is the product of that layer's L p and the ⌬P across it: Lp t (PL Ϫ P a) ϭ Lp e ϩ i (PL Ϫ Pi) ϭ Lp m ϩ I (Pi Ϫ Pa). Simple manipulation estimates the steady force/area, P L Ϫ Piϭ(Lp t /Lp e ϩ i )⌬P, on the endothelium. As shown in Fig. 6 , HgCl 2 blockade at 60 mmHg raises this steady force/area 55% from (2.55/6.85)60Ϸ22 to (1.74/3.06)60Ϸ34 mmHg at ⌬P ϭ 60 mmHg. Raising ⌬P from 60 to 100 mmHg, a ⌬P where our theory predicts a compressed SI even without HgCl 2 and increases the force/area on the endothelium to [(1.84/3.97)100]Ϸ46 mmHg. These numbers motivate the estimate below of the critical ⌬P needed for SI decompression with HgCl 2. Table 6 shows the main relations and layer L p and force/area estimates derived below.
As in Eq. 1, split the total specific resistance, 1/L p e ϩ i , of the endothelium ϩ SIϩ IEL fenestral entrance into the sum of endothelial, 1/L p e , plus SI ϩ fenestral, Lp i ϩ f , resistances ( Fig. 2A) , as follows:
When the SI is decompressed, the resistance of the SI plus fenestrae is much smaller than that of the endothelium, or Lp e ϳ Lp e ϩ i (60 mmHg 
Estimation of AQP1 Expression in the EC Membrane
Recall that 1/L p e ϩ i ϭ 1/Lp t Ϫ 1/Lp m ϩ I . If AQP accounts for part of the intrinsic Lp e , then blockade of AQP1 will alter the effective parameter Lp e ϩ i . Let Lp j be the junctional contribution to endothelial Lp e . The flows through inter-EC junctions and through the AQPs occur in parallel. The cell has more than one membrane that water must traverse in series (Fig. 2B) . Since Starling's law is linear, in parallel, linear conductivities add and, in series, their inverses add. Suppose the cell has m layers in series, the ith of which has ni AQPs per layer (i ϭ 1, . . . ., m). The ni AQPs in a layer operate in parallel. Thus, the total endothelial conductivity for this setup is Lp e Ϸ Lp j ϩ lp [⌺i(1/ni)] Ϫ1 . If ni ϭ n is i independent, then:
We now estimate derived EC AQP1 density estimate derived from hydrostatic pressure experiments further supports AQP1-mediated transcellular flow.
